137 cancer drugs capped at 30% trade margin from 9 Nov
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has imposed a trade margin rationalisation (TMR) on 137 identified non-scheduled anti-cancer drugs, capping the margin at 30% of the maximum…
